HAVIT Trademark

Trademark Overview


On Friday, August 19, 2022, a trademark application was filed for HAVIT with the United States Patent and Trademark Office. The USPTO has given the HAVIT trademark a serial number of 79361247. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 21, 2024. This trademark is owned by Pharm-A-Care Laboratories Pty. Limited. The HAVIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, veterinary, and therapeutic and sanitary preparations; antioxidant pills, decoctions for pharmaceutical purposes, digestives for pharmaceutical purposes, herbal teas for medicinal purposes, lozenges for pharmaceutical purposes, nutraceutical preparations for therapeutic or medical purposes, pastilles for pharmaceutical purposes, plant extracts for pharmaceutical purpose, sugar for medical purposes, syrups for pharmaceutical purposes, almond milk for pharmaceutical purposes, dietetic beverages adapted for medical purposes, dietetic foods adapted for medical purposes, dietetic substances adapted for medical use, malted milk beverages for medical purposes, medicated sweets; nutritional supplements; acai powder dietary supplements, albumin dietary supplements, casein dietary supplements, flaxseed dietary supplements, glucose dietary supplements, lecithin dietary supplements, pollen dietary supplements, propolis dietary supplements, protein dietary supplements, royal jelly d...
havit

General Information


Serial Number79361247
Word MarkHAVIT
Filing DateFriday, August 19, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, February 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical, veterinary, and therapeutic and sanitary preparations; antioxidant pills, decoctions for pharmaceutical purposes, digestives for pharmaceutical purposes, herbal teas for medicinal purposes, lozenges for pharmaceutical purposes, nutraceutical preparations for therapeutic or medical purposes, pastilles for pharmaceutical purposes, plant extracts for pharmaceutical purpose, sugar for medical purposes, syrups for pharmaceutical purposes, almond milk for pharmaceutical purposes, dietetic beverages adapted for medical purposes, dietetic foods adapted for medical purposes, dietetic substances adapted for medical use, malted milk beverages for medical purposes, medicated sweets; nutritional supplements; acai powder dietary supplements, albumin dietary supplements, casein dietary supplements, flaxseed dietary supplements, glucose dietary supplements, lecithin dietary supplements, pollen dietary supplements, propolis dietary supplements, protein dietary supplements, royal jelly dietary supplements, soy protein dietary supplements; sanitary preparations for human and veterinary use; dietetic substances adapted for medical use, food for babies; dietetic pills for cosmetic purposes; dietetic and slimming substances, preparations and foodstuffs and beverages in this class; powders for making beverages for medical or dietetic purposes (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); medical or dietetic probiotic drinks (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); formulated meal replacements, formulated supplementary foods, protein bars (nutritional supplements); plasters, materials for dressings; vitamin and mineral supplements; vitamin enriched gelatin based pastilles and confectionary (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); medicated foodstuffs and medicated confectionery including medicated chocolate; vitamins; probiotic preparations (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); supplements for humans and animals including protein supplements (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); medicinal herbs and herbal extracts; edible oils including marine oils being dietary supplements (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); marine oil for medical purposes; infants' and invalids' foods (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); vitamin enriched waters and beverages (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); medicated and vitamin or mineral enriched confectionery (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); medicinal teas; chlorophyll as a dietary supplement; dietary supplements; medicated foodstuffs; foodstuffs for infants or invalids (term too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharm-A-Care Laboratories Pty. Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, February 21, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, February 21, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 29, 2023REFUSAL PROCESSED BY IB
Saturday, August 5, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 5, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 28, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 7, 2023APPLICATION FILING RECEIPT MAILED
Friday, February 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB